ArticleDrug design, development and therapy2026

Hematological Safety of Contezolid versus Linezolid in Stage 5 Chronic Kidney Disease: An Active-Comparator New-User Retrospective Cohort Study.

Wenjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.